CD274 and neoplasm: However, further studies have shown that also patients with reduced PD-L1 expression on tumor cells can respond to the therapy, indicating that other cells within the tumor microenvironment (TME) are involved in the antitumor activity mediated by the inhibitors of PD-1PD-L1 axis (4).